Abstract
The signaling enzyme Phospholipase D (PLD) has been implicated in numerous cell biological processes, including Ras activation, cell spreading, stress fiber formation, chemotaxis, and vesicular trafficking during neurotransmitter and hormonal release. These observations have been mostly obtained from cell culture experiments using a primary alcohol to inhibit PLD activity or by modulating endogenous expression levels of the PLD1 and PLD2 isoforms. Since modulating PLD levels can have non-specific long-term effects and alcohols have been described to cause PLD-independent deleterious effects, the identification of potent specific small molecule PLD inhibitors is an important advance for the field. In this review, I will highlight the recent identification and characterization of chemical PLD inhibitors and describe their potential therapeutic interest in the treatment of human brain diseases/disorders and cancer metastasis.
Keywords: Phospholipase D, inhibitor, cancer, immunity, cognition
Current Chemical Biology
Title: Therapeutic Potentials of Recently Identified PLD Inhibitors
Volume: 4 Issue: 3
Author(s): Nicolas Vitale
Affiliation:
Keywords: Phospholipase D, inhibitor, cancer, immunity, cognition
Abstract: The signaling enzyme Phospholipase D (PLD) has been implicated in numerous cell biological processes, including Ras activation, cell spreading, stress fiber formation, chemotaxis, and vesicular trafficking during neurotransmitter and hormonal release. These observations have been mostly obtained from cell culture experiments using a primary alcohol to inhibit PLD activity or by modulating endogenous expression levels of the PLD1 and PLD2 isoforms. Since modulating PLD levels can have non-specific long-term effects and alcohols have been described to cause PLD-independent deleterious effects, the identification of potent specific small molecule PLD inhibitors is an important advance for the field. In this review, I will highlight the recent identification and characterization of chemical PLD inhibitors and describe their potential therapeutic interest in the treatment of human brain diseases/disorders and cancer metastasis.
Export Options
About this article
Cite this article as:
Vitale Nicolas, Therapeutic Potentials of Recently Identified PLD Inhibitors, Current Chemical Biology 2010; 4 (3) . https://dx.doi.org/10.2174/2212796811004030244
DOI https://dx.doi.org/10.2174/2212796811004030244 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Studies with Targeted Toxins in Malignant Glioma
Reviews on Recent Clinical Trials Exploring Mechanisms Underlying Extinction of Cue-Elicited Cocaine Seeking
Current Neuropharmacology Endothelial Progenitor Cells in Prehypertension
Current Pharmaceutical Design Gut Alterations in Septic Patients: A Biochemical Literature Review
Reviews on Recent Clinical Trials Alzheimer’s Disease and Environmental Exposure to Lead: The Epidemiologic Evidence and Potential Role of Epigenetics
Current Alzheimer Research An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
CNS & Neurological Disorders - Drug Targets Safety Considerations in the Use of Ketorolac for Postoperative Pain
Current Drug Safety CT and CT-guided Percutaneous Needle Biopsy in Diagnosis of Primary Pulmonary Cryptococcosis in Immunocompetent Patients
Current Medical Imaging The Role of 18 kDa Mitochondrial Translocator Protein (TSPO) in Programmed Cell Death, and Effects of Steroids on TSPO Expression
Current Molecular Medicine Editorial [Hot topic: Central and Peripheral Metabolic Changes in Neurodegenerative Diseases (Guest Editor: Ana Cristina Rego)]
Current Drug Targets Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Current Pharmaceutical Design Fetal Programming of the Human Brain: Is there a Link with Insurgence of Neurodegenerative Disorders in Adulthood?
Current Medicinal Chemistry Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Drug Discovery and Protein Tyrosine Phosphatases
Current Medicinal Chemistry Prevalence of Obesity, Hypertension, Diabetes, and Metabolic Syndrome and Its Cardiovascular Complications
Current Hypertension Reviews Withdrawal Notice: COVID-19: Outbreak to Global
Anti-Infective Agents Exploitation of Apoptosis Pathways for Childhood Leukemia
Current Pediatric Reviews Mannose Binding Lectin: A Potential Biomarker for Many Human Diseases
Current Medicinal Chemistry Silver and Other Metals in the Treatment of Gastrointestinal Diseases
Current Medicinal Chemistry α7 nAChR in Airway Respiratory Epithelial Cells
Current Drug Targets